Valsaram Dosage/Direction for Use

The recommended dose is one tablet daily and it can be taken along with water, regardless meal. If possible, it is recommended to take at the same time (i.e. morning) every day. It is also recommended to adjust a dose with individual component (amlodipine or valsartan) before taking this medication however, in case that blood pressure is not controlled by monotherapy of the individual components follows, it can be considered to switch to combination therapy with Amlodipine besylate + Valsartan (Valsaram).
5 mg/80 mg: It is administered to a patient whose blood pressure is not adequately controlled on monotherapy of Amlodipine 5 mg or Valsartan 80 mg.
5 mg/160 mg: It is administered to a patient whose blood pressure is not adequately controlled on monotherapy of Amlodipine 5 mg or Valsartan 160 mg.
10 mg/160 mg: It is administered to a patient whose blood pressure is not adequately controlled on monotherapy of Amlodipine 10 mg or Valsartan 160 mg.
In case of a patient taking Valsartan and Amlodipine concurrently, it can be switched to this medicine (combination medication of which individual active ingredient is same) for the sake of convenience.
Patients with renal impairment: No initial dosage adjustment is required for patients with mild or moderate renal impairment (creatinine clearance ≤10 mL/min) but this medicine should not be administered to patients with severe renal impairment (creatinine clearance ≥10 mL/min) and patients undergoing dialysis. In case of patients with moderate renal impairment, it is recommended to monitor potassium level and creatinine.
Patients with hepatic disorder: In case of patients with mild and moderate hepatic disorder, Valsartan daily dose should not exceed 80 mg. This medicine should not be administered to patient with severe hepatic impairment, with biliary cirrhotic liver and with biliary obstruction-cholestasis.
Elderly over 65 years old: Care should be taken upon dosage increase.
Children: It is not recommended to administer this medicine since safety, and efficacy are not established for children below 18 years old.